In March 2025, the company announced new designs for a immediate-to-shopper offering of its Wegovy weight loss drug. The company proven a whole new pharmacy, termed NovoCare, which would demand clients $499 monthly for use of the drug, below fifty percent the cost of the drug via other pharmaceutical distribution networks.[53]Troubles with diabetic